Switchover Time - Chronic Indications to Outdo Acute Segment in India

Released on: August 29, 2008, 3:09 am

Press Release Author: Shushmul Maheshwari

Industry: Healthcare

Press Release Summary: With increasing lifestyle changes and urbanization, India is
expected to see an upsurge in the number of chronic disease patients, creating
enough opportunities for drug makers.

Press Release Body: According to “Booming Pharma Sector in India”, a new
market research report by RNCOS, prevalence of chronic diseases is increasing at
alarming rates in India, and is expected to create a huge opportunity for drug

The report says that market for drugs against acute indications presently account
for around 75% of the total pharmaceutical sales. Owing to factors such as large
scale prevalence of infectious diseases and poor hygiene and sanitary conditions,
the market for drugs against acute indications will continue to dominate the overall
market, but the growth of the chronic segment is expected to far exceed that of the
acute segment.

Massive urbanization, sedentary lifestyles, growing cases of obesity, and an
increased switch over from traditional to western diets has led to a rapid rise in
the prevalence of chronic diseases in India. It’s expected that by 2015, the
country will have 62 Million coronary heart disease patients and 46 Million diabetes
patients. Similarly, the number of people suffering from depression and other
neurological disorders will also increase rapidly. This will make diabetes, cardiac
and CNS drugs the fastest growing therapy areas in the Indian pharmaceutical market.

The RNCOS research report forecasts that the market for diabetes drugs is expected
to grow fastest amongst all therapy areas at a CAGR of 16% between 2007 and 2011.
Cardiac and CNS drugs are projected to be the second and third fastest growing
segments, posting a CAGR of 15% and 12% respectively during the same timeframe.

“Booming Pharma Sector in India” is a unique market-based research study
that provides a detailed insight and objective analysis on the Indian pharmaceutical
market. It features a thorough statistical and analytical overview on the Indian
pharmaceutical market, and provides past, present and future data on the entire
structure, composition and working of the Indian pharmaceutical market. This study
intensively discusses the opportunities and challenges that are expected to arise
within and from the pharmaceutical market.

About RNCOS:

RNCOS, incorporated in the year 2002, is an industry research firm. It has a team of
industry experts who analyze data collected from credible sources. They provide
industry insights and analysis that helps corporations to take timely and accurate
business decision in today\'s globally competitive environment.

For more information visit: http://rncos.com/Report/IM131.htm
Current Industry News: http://www.rncos.com/Blog/

Web Site: http://www.rncos.com

Contact Details: 29, 1st Floor, Patparganj Industrial Area, Delhi 92

  • Printer Friendly Format
  • Back to previous page...
  • Back to home page...
  • Submit your press releases...